CLINICAL_TRIALS
trial_result
· 2014-03-14
Clinical Trial Update: A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edema [Phase 2]
Summary
A Phase 2 dose-defining study of OPC-41061 for hepatic edema due to cirrhosis has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Cirrhosis | Phase 2 | Status: COMPLETED | Results posted: 2014-03-14